Off-label use of breakthrough cancer pain drug linked to serious opioid addiction and death

[caption id="attachment_9396" align="alignright" width="300"] Source: Subsys[/caption] Cancer patients who are receiving regular pain medication and management can sometimes still experience sudden, intense flare-ups called breakthrough pain. Subsys, a fentanyl-based pain relief mouth spray, was developed by Insys Therapeutics and approved by the FDA to treat the condition. The drug delivers a painkiller mist 100...

read more